Research Library/ How This Industry Works / Archive / The Pharmaceutical War of Attrition: GLP-1,…

The Pharmaceutical War of Attrition: GLP-1, Oncology and the Infrastructure of Patient Access

Archive report from 11 May 2026. The era of the single blockbuster drug is over. We looked at the new battlegrounds in obesity drugs, cancer and patient access.

Published 11 May 2026 Data cutoff 11 May 2026 Industries & Trends team

Research lead: Denys Zavertany

The Quick Explanation is free to read

Continue with a free trial

Get full access to our independent research for 7 days.

Start free trial

Or read the Quick Explanation. It is free

Educational content only. Not investment advice.